Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 2Phase 2/3 2Phase 1 2Phase NA 1Phase 2 1

Status

Terminated 5Completed 3Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Conditions

Fatigue 3Neoplasms 1

Interventions

Cyclophosphamide 297Cisplatin 297Paclitaxel 258Radiotherapy 253Fluorouracil 234Carboplatin 234Docetaxel 231Doxorubicin 212Dexamethasone 164Gemcitabine 155Vincristine 143Etoposide 133Leucovorin 132Capecitabine 129Bevacizumab 129Prednisone 124Rituximab 118Methotrexate 117Cytarabine 108Filgrastim 99Trastuzumab 98Oxaliplatin 96pembrolizumab 81Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Nivolumab 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Completed × Methylphenidate × Clear all
NCT00003266 2023-06-18

Methylphenidate in Treating Patients With Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed
200 enrolled

Fatigue

NCT05041946 2022-09-29

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

M.D. Anderson Cancer Center

Phase 3 Completed
112 enrolled

Fatigue, Neoplasms

NCT00376675 2016-08-01

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
148 enrolled 24 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡